SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-10-036912
Filing Date
2010-09-10
Accepted
2010-09-10 17:20:06
Documents
4
Period of Report
2010-09-09
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 REXAHN PHARMACEUTICALS, INC 8-K 9-9-2010 form8k.htm 8-K 27924
2 EXHIBIT 10.1 ex10_1.htm EX-10.1 105317
3 EXHIBIT 10.2 ex10_2.htm EX-10.2 114027
4 EXHIBIT 10.3 ex10_3.htm EX-10.3 115588
  Complete submission text file 0001140361-10-036912.txt   364675
Mailing Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850
Business Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850 2402685300
REXAHN PHARMACEUTICALS, INC. (Filer) CIK: 0001228627 (see all company filings)

IRS No.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34079 | Film No.: 101067688
SIC: 2834 Pharmaceutical Preparations